Selected research
Industry Research
Arteriovenous Fistula Treatment Industry Research Report 2026
Market perspective
The global Arteriovenous Fistula Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Arteriovenous Fistula Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Arteriovenous Fistula Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Arteriovenous Fistula Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Arteriovenous Fistula Treatment include Teleflex Incorporated, Medtronic, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen Ag, Poly Medicure Limited, NxStage Medical, Cook Medical and Becton Dickinson, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Arteriovenous Fistula Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Arteriovenous Fistula Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Arteriovenous Fistula Treatment Market by Company
Teleflex Incorporated
Medtronic
Fresenius Medical Care AG & Co. KGaA
B. Braun Melsungen Ag
Poly Medicure Limited
NxStage Medical
Cook Medical
Becton Dickinson
Arteriovenous Fistula Treatment Segment by Type
Peripheral Arteriovenous Fistulas
Dural Arteriovenous Fistulas
Pial or Cerebral Arteriovenous Fistulas
Arteriovenous Fistula Treatment Segment by Application
Drugs
Surgery
Transcatheter Embolization
Ultrasound-guided Compression
Arteriovenous Fistula Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arteriovenous Fistula Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arteriovenous Fistula Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arteriovenous Fistula Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Arteriovenous Fistula Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Peripheral Arteriovenous Fistulas
- Dural Arteriovenous Fistulas
- Pial or Cerebral Arteriovenous Fistulas
Applications
- Drugs
- Surgery
- Transcatheter Embolization
- Ultrasound-guided Compression
Companies covered
- Teleflex Incorporated
- Medtronic
- Fresenius Medical Care AG & Co. KGaA
- B. Braun Melsungen Ag
- Poly Medicure Limited
- NxStage Medical
- Cook Medical
- Becton Dickinson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Arteriovenous Fistula Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Peripheral Arteriovenous Fistulas
- 2.2.3 Dural Arteriovenous Fistulas
- 2.2.4 Pial or Cerebral Arteriovenous Fistulas
- 2.3 Arteriovenous Fistula Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drugs
- 2.3.3 Surgery
- 2.3.4 Transcatheter Embolization
- 2.3.5 Ultrasound-guided Compression
- 2.4 Assumptions and Limitations
3 Arteriovenous Fistula Treatment Breakdown Data by Type
- 3.1 Global Arteriovenous Fistula Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Arteriovenous Fistula Treatment Forecasted Market Size by Type (2027-2032)
4 Arteriovenous Fistula Treatment Breakdown Data by Application
- 4.1 Global Arteriovenous Fistula Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Arteriovenous Fistula Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Arteriovenous Fistula Treatment Market Perspective (2021-2032)
- 5.2 Global Arteriovenous Fistula Treatment Growth Trends by Region
- 5.2.1 Global Arteriovenous Fistula Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Arteriovenous Fistula Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Arteriovenous Fistula Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Arteriovenous Fistula Treatment Market Dynamics
- 5.3.1 Arteriovenous Fistula Treatment Industry Trends
- 5.3.2 Arteriovenous Fistula Treatment Market Drivers
- 5.3.3 Arteriovenous Fistula Treatment Market Challenges
- 5.3.4 Arteriovenous Fistula Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Arteriovenous Fistula Treatment Players by Revenue
- 6.1.1 Global Top Arteriovenous Fistula Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Arteriovenous Fistula Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Arteriovenous Fistula Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Arteriovenous Fistula Treatment Head Office and Area Served
- 6.4 Global Arteriovenous Fistula Treatment Players, Product Type & Application
- 6.5 Global Arteriovenous Fistula Treatment Manufacturers Established Date
- 6.6 Global Arteriovenous Fistula Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Arteriovenous Fistula Treatment Market Size (2021-2032)
- 7.2 North America Arteriovenous Fistula Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 7.4 North America Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Arteriovenous Fistula Treatment Market Size (2021-2032)
- 8.2 Europe Arteriovenous Fistula Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 8.4 Europe Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Arteriovenous Fistula Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Arteriovenous Fistula Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Arteriovenous Fistula Treatment Market Size (2021-2032)
- 10.2 South America Arteriovenous Fistula Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 10.4 South America Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Arteriovenous Fistula Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Arteriovenous Fistula Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Arteriovenous Fistula Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teleflex Incorporated
- 12.1.1 Teleflex Incorporated Company Information
- 12.1.2 Teleflex Incorporated Business Overview
- 12.1.3 Teleflex Incorporated Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.1.4 Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio
- 12.1.5 Teleflex Incorporated Recent Developments
- 12.2 Medtronic
- 12.2.1 Medtronic Company Information
- 12.2.2 Medtronic Business Overview
- 12.2.3 Medtronic Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.2.4 Medtronic Arteriovenous Fistula Treatment Product Portfolio
- 12.2.5 Medtronic Recent Developments
- 12.3 Fresenius Medical Care AG & Co. KGaA
- 12.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
- 12.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview
- 12.3.3 Fresenius Medical Care AG & Co. KGaA Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.3.4 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio
- 12.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
- 12.4 B. Braun Melsungen Ag
- 12.4.1 B. Braun Melsungen Ag Company Information
- 12.4.2 B. Braun Melsungen Ag Business Overview
- 12.4.3 B. Braun Melsungen Ag Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.4.4 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio
- 12.4.5 B. Braun Melsungen Ag Recent Developments
- 12.5 Poly Medicure Limited
- 12.5.1 Poly Medicure Limited Company Information
- 12.5.2 Poly Medicure Limited Business Overview
- 12.5.3 Poly Medicure Limited Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.5.4 Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio
- 12.5.5 Poly Medicure Limited Recent Developments
- 12.6 NxStage Medical
- 12.6.1 NxStage Medical Company Information
- 12.6.2 NxStage Medical Business Overview
- 12.6.3 NxStage Medical Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.6.4 NxStage Medical Arteriovenous Fistula Treatment Product Portfolio
- 12.6.5 NxStage Medical Recent Developments
- 12.7 Cook Medical
- 12.7.1 Cook Medical Company Information
- 12.7.2 Cook Medical Business Overview
- 12.7.3 Cook Medical Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.7.4 Cook Medical Arteriovenous Fistula Treatment Product Portfolio
- 12.7.5 Cook Medical Recent Developments
- 12.8 Becton Dickinson
- 12.8.1 Becton Dickinson Company Information
- 12.8.2 Becton Dickinson Business Overview
- 12.8.3 Becton Dickinson Revenue in Arteriovenous Fistula Treatment Business (2021-2026)
- 12.8.4 Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio
- 12.8.5 Becton Dickinson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst